Lexington, KY – Carina Medical LLC announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for INTDose. INTDose is a Monte Carlo (MC)-based software for independent dose verification in radiotherapy treatment planning. Monte Carlo simulation is regarded as the gold standard for estimating the amount of energy deposited into a medium by ionizing radiation; however, the clinical utility of using MC simulations for independent dose calculations is often hindered by the computational resources and time required to run these simulations. INTDose provides a solution to these bottlenecks by utilizing virtual source models and parallel processing to provide a high speed and accurate validation of treatment plans for delivery methods including TomoTherapy, conventional Varian Linac IMRT, VMAT, and Varian Halcyon. The product also includes a user-friendly private-cloud-based interface, a fully automated workflow, and scripting compatibility with Varian's Eclipse treatment planning system (TPS) to allow for the incorporation into clinical workflows with high customizability.
Continue readingLexington, KY – Carina Medical LLC announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for INTContour. INTContour is an AI-based automatic contouring software that covers more than 60 organs from all anatomical body parts. Based on award-winning algorithms, the segmentation performance is independently validated in multiple academic institutions with high accuracy and robustness. The product also includes a user-friendly private-cloud-based interface that is designed to fit into clinical workflows with high customizability.
Continue readingLexington, KY -- Carina Medical has received a $2M award from the National Cancer Institute to continue the development of AI based auto-segmentation software for radiation therapy treatment planning.
Carina Medical will continue to develop novel solutions for more efficient radiation treatment planning. It will support both CT- and MRI-based organ segmentation and site-specific segmentation models to increase the robustness of the AI system.
Carina Medical is in collaboration with the University of Kentucky and the University of California, Davis to develop and validate the auto-segmentation product.
Frankfort, KY -- The Cabinet for Economic Development KY Innovation awarded Carina Medical $150K SBIR/STTR Matching Funds.
“SBIR/STTR funds are a vital component in launching and growing innovative, high-tech companies here in Kentucky,” said Gov. Matt Bevin. “The commonwealth’s matching program is one of the strongest in the nation, enabling us to support early-stage companies with cutting-edge technologies. This year’s recipients are a testament to the outstanding work being done in our state across many disciplines. We look forward to watching them flourish right here in America’s engineering and manufacturing center of excellence.”
Lexington, KY –- Carina Medical has received a $300,000 Phase I SBIR award from the National Institute of Health to develop AI assisted auto-segmentation software for radiation therapy treatment planning.
Continue reading